Last Posted: Apr 30, 2020
- Clinical utility of multigene analysis in over 25,000 patients with neuromuscular disorders.
Winder Thomas L et al. Neurology. Genetics 2020 Apr 6(2) e412 - The care of patients with Duchenne, Becker and other muscular dystrophies in the COVID-19 pandemic.
Veerapandiyan Aravindhan et al. Muscle & nerve 2020 Apr - Early detection of superspreaders by mass group pool testing can mitigate COVID-19 pandemic
MB Gongalsky, MEDRXIV, April 27, 2020 - Duchenne Muscular Dystrophy Education Series
American Academy of Pediatrics - [Clinical practice guidelines for Duchenne muscular dystrophy].
Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association et al. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020 Mar 37(3) 258-262 - The race to unravel the United States’ biggest coronavirus outbreak
A Maxmen, Nature, March 6, 2020 - Is it the right time for an infant screening for Duchenne muscular dystrophy?
Vita Gian Luca et al. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2020 Feb - Quantitative coordination evaluation for screening children with Duchenne muscular dystrophy.
An Jian et al. Chaos (Woodbury, N.Y.) 2020 Feb 30(2) 023116 - Comprehensive genetic diagnosis of patients with Duchenne/Becker muscular dystrophy (DMD/BMD) and pathogenicity analysis of splice site variants in the DMD gene.
Yang Yan-Mei et al. Journal of Zhejiang University. Science. B 20(9) 753-765 - Molecular and Histopathological Characterization of Patients Presenting with the Duchenne Muscular Dystrophy Phenotype in a Tertiary Care Center in Southern India.
Tallapaka Karthik et al. Indian pediatrics 2019 56(7) 556-559
.png)
No hay comentarios:
Publicar un comentario